Kievit wins infant nutrition tech innovation award
Dutch firm, FrieslandCampina Kievit, has been recognised for its encapsulation work in the area of infant nutrition, by market researcher, Frost & Sullivan.
Archives for April 16, 2009
Digestion and weight are health priorities for Brazilians: Survey
Consumer research by ingredients firm Tate & Lyle reveals that over half of Brazilian consumers are looking for healthier eating options, with areas of focus being weight management and digestion.
Oat extract may cut cigarette cravings: Pilot study
A standardised oat extract may reduce cravings for smoking and offer would-be quitters an alternative to the patches and gums, suggests research from Japan.
French cranberry claim unaffected by EFSA stance, says Ocean Spray
The world’s only officially mandated cranberry health claim will not be affected by the recent rejection of a similar claim at European Union level, according to the company that submitted the claim, Ocean Spray.
Kid’s omega-3/probiotic supplement launched in Europe
Israeli firm, Anlit Ltd, has launched a children’s probiotic and omega-3 supplement in European markets after notching success with the product in Israel.
Low vitamin A and C levels may boost asthma risk
Low dietary intakes of vitamins A and C may increase the risk of developing asthma, suggests a review of 40 studies and 30 years of research.
'Fishy' omega-3 DHA leads to the courts
A US candy and snack bar manufacturer has been saddled with a bill of almost $100,000, after a DHA fortification attempt went wrong.
Consider kosher and halal for wider appeal, says market research
Kosher and halal foods hold consumer appeal that goes far beyond any ethnic or religious niche, according to a new report from Packaged Facts.
Danone bins EU probiotic gut health claim submissions
French dairy giant Danone has withdrawn the EU health claim applications for its market leading probiotic yoghurt products Activia and Actimel.
Hemp investment to boost global presence
Manitoba Harvest Hemp Foods & Oils has received undisclosed funding from fellow Canadian biotech-focused investment form, Avrio Ventures, which the rapidly growing company says will allow it to “accomplish its five year plan”.